"CoxHealth in Branson, MO is the area leader in health care and community involvement, with six hospitals, more than 80 clinics, five ERs and nearly 12,000 employees throughout southwest Missouri. We offer a wide range of treatments and services to help with whatever health needs you might have. Whether you're about to become a parent, have an illness or need medical information, we're here for you. And if your goal is to live a healthy, balanced life with the best tools available, we can help with that, too."

During the past decade, Cox Cancer Center Branson conducted 121 clinical trials. In the 10-year time frame, 121 clinical trials started and 59 clinical trials were completed, i.e. on average, 48.8% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 47 clinical trials were completed. i.e. 102.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cox Cancer Center Branson" #1 sponsor was "National Cancer Institute (NCI)" with 82 trials, followed by "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored, "SWOG Cancer Research Network" with 18 trials sponsored and "Wake Forest University Health Sciences" with 18 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cox Cancer Center Branson" #1 collaborator was "National Cancer Institute (NCI)" with 76 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Cox Cancer Center Branson" are "Recurrent Breast Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Breast Cancer AJCC v6 and v7" (7 trials) and "Recurrent Fallopian Tube Carcinoma" (6 trials). Many other conditions were trialed in "Cox Cancer Center Branson" in a lesser frequency.

Most popular intervention types in "Cox Cancer Center Branson" are "Drug" (126 trials), "Other" (107 trials), "Biological" (67 trials), "Procedure" (39 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (42 trials), "Questionnaire Administration" (21 trials), "Biospecimen Collection" (20 trials) and "Carboplatin" (19 trials). Other intervention names were less common.

The vast majority of trials in "Cox Cancer Center Branson" are 128 trials for "All" genders, 29 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Cox Cancer Center Branson". undefined are not yet recruiting, 45 are recruiting, 85 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Cox Cancer Center Branson, 5 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Cox Cancer Center Branson, 2 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".